Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein

Toward optimal therapy for inhibitors in hemophilia

(2014) C. L. Kempton et al.   BLOOD

Definitions in hemophilia: communication from the SSC of the ISTH

(2014) V. S. Blanchette et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Design of the INHIBIT trial: preventing inhibitors by avoiding ‘danger’, prolonging half-life and promoting tolerance

(2014) Margaret V Ragni et al.   Expert Review of Hematology

A new recombinant factor VIII: from genetics to clinical use

(2014) Elena Santagostino   Drug Design Development and Therapy

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

(2013) J. Mahlangu et al.   BLOOD

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

(2012) J. S. Powell et al.   BLOOD

Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice

(2012) Gary Benson et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The Immunologic Functions of the Neonatal Fc Receptor for IgG

(2012) Timo Rath et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice

(2010) Massimo Franchini et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Management of Haemophilia A-Inhibitor Patients: Clinical and Regulatory Perspectives

(2009) Zera Tellier et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

How we treat a hemophilia A patient with a factor VIII inhibitor

(2008) C. L. Kempton et al.   BLOOD

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

(2008) A. S. De Groot et al.   BLOOD